Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders.
about
A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor ModelNeuronal migration abnormalities and its possible implications for schizophreniaTranslating the MAM model of psychosis to humansThe reuniens and rhomboid nuclei: neuroanatomy, electrophysiological characteristics and behavioral implicationsThe role of α5 GABAA receptor agonists in the treatment of cognitive deficits in schizophreniaFrom tones in tinnitus to sensed social interaction in schizophrenia: how understanding cortical organization can inform the study of hallucinations and psychosisGlutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related PhenotypesStructure of excitatory synapses and GABAA receptor localization at inhibitory synapses are regulated by neuroplastin-65Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course.Neuronal effects of nicotine during auditory selective attention in schizophreniaEffects of a ketogenic diet on auditory gating in DBA/2 mice: A proof-of-concept studyMolecular substrates of schizophrenia: homeostatic signaling to connectivityStructural pathology underlying neuroendocrine dysfunction in schizophrenia.Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia.Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis.Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis.Hippocampal CA1 region shows differential regulation of gene expression in mice displaying extremes in behavioral sensitization to amphetamine: relevance for psychosis susceptibility?Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes.Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.Using computational patients to evaluate illness mechanisms in schizophrenia.Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion.Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia.Brain-derived neurotrophic factor (BDNF) Val(66)Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia.Annual research review: Current limitations and future directions in MRI studies of child- and adult-onset developmental psychopathologies.Stem cell-derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent modelIsolating pathogenic mechanisms embedded within the hippocampal circuit through regional vulnerability.Human hippocampal subfields in young adults at 7.0 T: feasibility of imagingImaging the human medial temporal lobe with high-resolution fMRI.Neuroimaging biomarkers for early drug development in schizophreniaHippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophreniaAnterior-posterior cerebral blood volume gradient in human subiculum.Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia.Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophreniaHippocampal substructural vulnerability to sleep disturbance and cognitive impairment in patients with chronic primary insomnia: magnetic resonance imaging morphometry.An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis.Increased hippocampal CA1 cerebral blood volume in schizophrenia.Polyamine pathway contributes to the pathogenesis of Parkinson disease.A pathophysiological framework of hippocampal dysfunction in ageing and disease
P2860
Q26774869-909FD910-C4E6-44E3-BD31-F8067DF3AC38Q26824953-AF2FDD46-3996-4C24-A6D5-F6B190D76958Q26860217-562CBC9B-D374-4703-9307-1845CCF1BAF9Q27000531-D4253EC4-3BA8-476A-8D8B-6ABB8EED2FCEQ27026637-A85A3AA1-5FEF-4A93-9E53-22A85A0B9AC2Q27027952-C6C856CE-52DC-4099-8762-5E69BD99E41CQ27310915-3D74BF18-9BB6-4BED-9EC5-F91DA0285FABQ28585420-AD083B29-8780-4A72-BB28-AAD031395A6CQ30365823-5FCE49DD-F4D0-4B5F-BFB0-5EFFFD5710F8Q30366764-41EA615B-39A0-401D-B8FE-DE0B1E07DBC6Q30368931-FF9DD03A-968F-4FB0-A706-F4298B3D997DQ30383611-5393175A-8BB3-4DF6-903E-0EBBD2A30D43Q30409351-A148203D-831A-4DB5-9D51-DE1263ADEA7EQ30412701-28DD5AB2-06F2-4410-BD22-1009B65AC02DQ30450082-B19F5A92-5010-44C3-A720-4261CDA65680Q30454958-1036B1A7-5C93-4B2C-8CD3-42DA41456521Q30466268-552943C1-44B3-49CB-88F7-A2994EBC06F4Q30473855-888BB9E1-0A1B-4761-9AAF-11DA4D76AFF2Q30478804-6BB213AF-5A67-4745-8DD2-9FBCC1513712Q30483032-C3827C5E-2045-4384-B5EC-C3EC5C9A3B96Q30500752-18857763-6026-46FB-9B10-9DEFC1853D74Q30531730-BC19405F-EEE0-4057-89B0-CC3EAB0821ADQ30540732-9FF507B5-AB22-4CE9-8084-46C590C0EE8CQ30586016-D9E5C4D6-14BE-49F8-A867-DE35B7548770Q30736435-1EB3BF69-1FEA-4E77-A576-4F60233337FAQ30837351-E231000B-5ECD-44A6-AF12-D132E2D9B35EQ30857122-E80CBCA5-9E27-42BD-8A05-7793451160E0Q33528381-6B51467B-59A7-4F20-9310-B5855CA66D91Q33531598-3609C818-36C7-4104-BE4A-BD6AA7ACFF25Q33632516-019E4D31-B3EE-4BDE-BFA6-22FA98674BE9Q33637819-CEA268BB-7199-4E40-934B-ACE29E387EB3Q33688290-26E7A79F-FF99-4CA0-881E-ED930B28D7BDQ33857105-F5D3B3E2-DA0A-4F05-805F-12D4C5195594Q33865310-209CCD3C-770B-405F-912B-2BD27FB5DD3CQ33903209-4243D05C-24CC-4C1F-83D0-DCF4BBCB73EFQ33933997-7294C846-1BDF-4B2F-8FFA-E19BF4AA4926Q34071212-81B78DD7-3782-4BDB-A9F8-46005DC28F24Q34079242-AB79ABCE-026E-4802-9B83-0E99FF8C0BF3Q34165462-20D5B602-A74E-4997-B1A6-3F1866186FACQ34214060-E590FBFB-B58F-424C-8ABE-921DCE2456BB
P2860
Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Differential targeting of the ...... d related psychotic disorders.
@ast
Differential targeting of the ...... d related psychotic disorders.
@en
Differential targeting of the ...... d related psychotic disorders.
@nl
type
label
Differential targeting of the ...... d related psychotic disorders.
@ast
Differential targeting of the ...... d related psychotic disorders.
@en
Differential targeting of the ...... d related psychotic disorders.
@nl
prefLabel
Differential targeting of the ...... d related psychotic disorders.
@ast
Differential targeting of the ...... d related psychotic disorders.
@en
Differential targeting of the ...... d related psychotic disorders.
@nl
P2093
P2860
P1433
P1476
Differential targeting of the ...... d related psychotic disorders.
@en
P2093
Holly Moore
Nicole M Lewandowski
Scott A Schobel
Scott A Small
Truman Brown
P2860
P304
P356
10.1001/ARCHGENPSYCHIATRY.2009.115
P407
P577
2009-09-01T00:00:00Z